Piperazine derivative

Details Piperazine derivative Piperazine derivative

C - Chemistry, Metallurgy

07

D

C07D 295/12 (2006.01) A61K 31/496 (2006.01) A61K 31/517 (2006.01) A61P 3/04 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01) A61P 43/00 (2006.01) C07D 209/48 (2006.01) C07D 211/26 (2006.01) C07D 225/02 (2006.01) C07D 231/12 (2006.01) C07D 233/70 (2006.01) C07D 233/84 (2006.01) C07D 239/26 (2006.01) C07D 239/42 (2006.01) C07D 239/96 (2006.01) C07D 261/08 (2006.01) C07D 263/32 (2006.01) C07D 277/28 (2006.01) C07D 277/34 (2006.01) C07D 277/40 (2006.01) C07D 277/56 (2006.01) C07D 295/02 (2006.01) C07D 295/13

Patent

CA 2470808

A piperazine derivative represented by the formula (1) [wherein n is an integer of 1 to 8; R1 represents hydrogen or C1-10 alkyl; A represents CH or nitrogen; Ar1 represents phenyl or substituted phenyl; and Y represents a group represented by the formula Y1-Y2-Ar2 or Y3-Y4(Ar5)-Ar6] or a pharmaceutically acceptable salt of the derivative. The novel piperazine derivative has MC4 receptor antagonistic activity.

L'invention concerne un dérivé de piperazine représenté par la formule (1) ou un sel pharmaceutiquement acceptable de ce dérivé. Dans la formule (1), n vaut un entier de 1 à 8 ; R?1¿ représente hydrogène ou alkyle C¿1-10 ?; A représente CH ou azote ; Ar?1¿ représente phényle ou phényle substitué ; et Y représente un groupe représenté par la formule Y?1¿-Y?2¿-Ar?2¿ ou Y?3¿-Y?4¿-(Ar?5¿)-Ar?6¿. Ce nouveau dérivé de piperazine présente une activité d'antagoniste du récepteur MC4.

Affiliated with

Also associated with

Rating

Piperazine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1786026